Prostate cancer trials in India

In India 8 Also abroad 1481

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Where
Amravati, Bengaluru, Bhubaneswar, Gorimedu, Hyderabad, Jaipur, Kochi, Kolkata, Mumbai, Nadiād, New Delhi, Thiruvananthapuram, Varanasi, Vellalasseri
Age
18 years and over
People
50
Run by
Bayer
See details and how to joinNCT05348876
No phaseNot yet taking people in India
A Study of Darolutamide Plus Androgen Deprivation Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer in India
Where
Multiple Locations
Age
18 years and over
People
60
Run by
Bayer
See details and how to joinNCT07806591
Phase 3Taking people
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Where
Bangalore, Gūrgaon, Navi Mumbai
Age
18 years and over
People
670 worldwide
Run by
AstraZeneca
See details and how to joinNCT07611110
Phase 3Taking people
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Where
Bengaluru, Gurgaon, Mumbai
Age
18 years to 100 years
People
940 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06855277
Phase 3Taking people
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Where
Ansārinagar, Bangalore, Delhi, Kannur, Nagpur, New Delhi, Vadodara
Age
18 years and over
People
1,330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00
Phase 3Taking people
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Where
Ansārinagar, Babgalore, Calicut, Delhi, Hyderabad, Kannur, Kanpur, Mumbai, Nagpur, Varanasi
Age
18 years and over
People
700 worldwide
Run by
AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00
Phase 2Not yet taking people in India
A Study Testing if Patients With Advanced Prostate Cancer Who Are Responding Well to Combination Treatment Can Safely Reduce Their Medication to a Single Hormone Therapy, Compared to Continuing Their Current Drugs
Where
Mumbai
Age
18 years to 80 years
People
170
Run by
Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute
See details and how to joinNCT07838753
Phase 2Taking people
Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial
Where
Mumbai
Age
19 years to 99 years
People
206
Run by
Tata Memorial Centre
See details and how to joinNCT06818682